Oryzon Genomics SA's market cap is currently €241.29M. The company's EPS TTM is €0; its P/E ratio is ―; Oryzon Genomics SA is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is €-0.03. See an overview of income statement, balance sheet, and cash flow financials.
